The Evaluation of Clinical Outcomes Assessments and Digital Health Technologies in Clinical Trials for Obesity

Overview

Journal J Patient Rep Outcomes

Specialty Health Services

Date 2025 Feb 20

PMID 39976863

Authors

Iris A Goetz

Carolyn Sutter

Traci Abraham

Chisom Kanu

Kristina S Boye

Tara Symonds

Affiliations

Soon will be listed here.

Abstract

Background: Clinical trials for obesity have traditionally focused on weight loss and resolution of comorbidities as primary outcomes. However, secondary outcomes, such as the impact of weight reduction on patient experience, like health-related quality of life (HRQoL), have increasingly been recognized as important. Therefore, a review was conducted to determine the Clinical Outcome Assessments (COAs) and Digital Health Technologies (DHTs) used in clinical trials for obesity to assess the patient experience.

Methods: Two clinical trial databases (United States & European Union) were reviewed to identify Phase 2-4 clinical trials for obesity (2018-2023). A targeted literature review was also conducted using the OVID database to identify clinical trial for obesity publications which included COAs/DHTs (2010-2023).

Result: Trials from the databases (n = 53) and publications (n = 42) were included in data extraction (N = 73). This resulted in identification of 108 COAs, the majority being patient-reported outcome (PRO) measures (n = 83), but also 24 performance outcomes (PerfO) measures, and 1 composite PRO-clinician-reported outcomes (ClinRO) measure, as well as 2 DHTs. The most frequently identified PRO measures were the Short Form 36 and the Impact of Weight on Quality of Life Lite Clinical Trials. Twenty-four PerfO measures were also identified, with the 6-minute walk test being most common. These measures were most often used to construct secondary endpoints, with physical function (PF) being the most frequently specified domain. PRO measures assessing eating-related thoughts/behaviours, physical activity, and disordered eating were also frequently included, although individual measures varied widely across trials.

Conclusion: Review of COAs and DHTs in registered clinical trials and publications for obesity found that PRO measures were the most common type of COA used to develop endpoints with current use of DHTs limited. Specifically, the physical function domain of multidimensional patient-reported outcome measures assessing health-related quality of life were often used to construct secondary endpoints. Further work is warranted to assess how the COAs and DHT data collected in clinical trials are viewed by regulators and payers.

References

Izci B, Ardic S, Firat H, Sahin A, Altinors M, Karacan I . Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath. 2007; 12(2):161-8. DOI: 10.1007/s11325-007-0145-7. View

ONeil P, Rubino D . Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program. Postgrad Med. 2023; 134(sup1):28-36. DOI: 10.1080/00325481.2022.2150006. View

Heller G, Manuguerra M, Chow R . How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scand J Pain. 2017; 13:67-75. DOI: 10.1016/j.sjpain.2016.06.012. View

Fontaine K, Barofsky I . Obesity and health-related quality of life. Obes Rev. 2002; 2(3):173-82. DOI: 10.1046/j.1467-789x.2001.00032.x. View

Rose J, Vaewsorn A, Rosselli-Navarra F, Wilson G, Weissman R . Test-retest reliability of the eating disorder examination-questionnaire (EDE-Q) in a college sample. J Eat Disord. 2014; 1:42. PMC: 4081765. DOI: 10.1186/2050-2974-1-42. View

Reilly M, Gerlier L, Brabant Y, Brown M . Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin Ther. 2008; 30(2):393-404. DOI: 10.1016/j.clinthera.2008.02.016. View

Delgado D, Lambert B, Boutris N, McCulloch P, Robbins A, Moreno M . Validation of Digital Visual Analog Scale Pain Scoring With a Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop Surg Glob Res Rev. 2018; 2(3):e088. PMC: 6132313. DOI: 10.5435/JAAOSGlobal-D-17-00088. View

Pyper E, McKeown S, Hartmann-Boyce J, Powell J . Digital Health Technology for Real-World Clinical Outcome Measurement Using Patient-Generated Data: Systematic Scoping Review. J Med Internet Res. 2023; 25:e46992. PMC: 10600647. DOI: 10.2196/46992. View

Smith K, Smith M . Obesity Statistics. Prim Care. 2016; 43(1):121-35, ix. DOI: 10.1016/j.pop.2015.10.001. View

10.

Pantalone K, Smolarz B, Ramasamy A, Baz Hecht M, Harty B, Rogen B . Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial. JAMA Netw Open. 2021; 4(7):e2116595. PMC: 8278271. DOI: 10.1001/jamanetworkopen.2021.16595. View

11.

Jinks C, Jordan K, Croft P . Measuring the population impact of knee pain and disability with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Pain. 2002; 100(1-2):55-64. DOI: 10.1016/s0304-3959(02)00239-7. View

12.

Izci B, Firat H, Ardic S, Kokturk O, Gelir E, Altinors M . Adaptation of functional outcomes of sleep questionnaire (FOSQ) to Turkish population. Tuberk Toraks. 2004; 52(3):224-30. View

13.

de Vries C, Terwee C, Al Nawas M, van Wagensveld B, Janssen I, Liem R . Outcomes of the first global multidisciplinary consensus meeting including persons living with obesity to standardize patient-reported outcome measurement in obesity treatment research. Obes Rev. 2022; 23(8):e13452. PMC: 9539945. DOI: 10.1111/obr.13452. View

14.

Enright P . The six-minute walk test. Respir Care. 2003; 48(8):783-5. View

15.

Kolotkin R, Williams V, von Huth Smith L, Meincke H, Qin S, Williams N . Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT). Clin Obes. 2021; 11(5):e12477. PMC: 9285468. DOI: 10.1111/cob.12477. View

16.

Chooi Y, Ding C, Magkos F . The epidemiology of obesity. Metabolism. 2018; 92:6-10. DOI: 10.1016/j.metabol.2018.09.005. View

17.

Perrot S, Lanteri-Minet M . Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice. Eur J Pain. 2019; 23(6):1117-1128. DOI: 10.1002/ejp.1378. View

18.

Jennings K, Phillips K . Eating Disorder Examination-Questionnaire (EDE-Q): Norms for Clinical Sample of Female Adolescents with Anorexia Nervosa. Arch Psychiatr Nurs. 2017; 31(6):578-581. PMC: 5728684. DOI: 10.1016/j.apnu.2017.08.002. View

19.

Green C, Porter C, Bresnahan D, Spertus J . Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000; 35(5):1245-55. DOI: 10.1016/s0735-1097(00)00531-3. View

20.

Stephenson J, Smith C, Kearns B, Haywood A, Bissell P . The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public Health. 2021; 21(1):1990. PMC: 8567540. DOI: 10.1186/s12889-021-12009-8. View